Number of Shares
-
Current Holdings Value*
N/A
% of Portfolio
0%
Total Estimate Gain
$-3.72 Mil
% of Total Estimate Gain
-53.38%

Checkpoint Capital L.P.'s Pliant Therapeutics Inc Holding Summary

As of 2025-03-31, Checkpoint Capital L.P. held - shares of Pliant Therapeutics Inc(PLRX), totaling N/A. This investment constitutes 0% of their stock portfolio, and Checkpoint Capital L.P. now holds 0% of the outstanding Pliant Therapeutics Inc(PLRX) stock.

The initial trade took place in 2024Q2. And since then Checkpoint Capital L.P. has made 3 purchases of PLRX, at an average price of $13.02, for a total of 535,494.00 shares. In addition, there have been 1 sales at an average price of $6.07 for 535,494.00 shares. Based on historical transaction data and PLRX's current price of $1.20, Checkpoint Capital L.P.'s estimated gain on his PLRX holdings is $-3.72 Mil, reflecting a -53.38% gain to date.

Checkpoint Capital L.P. PLRX ($1.20) Holding Chart

Checkpoint Capital L.P. PLRX ($1.20) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price $-/Share
Shares Sold 0 Average Price $-/Share
Current Price $0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1